Summary
This paper discusses a clinical trial that tests the use of morning light treatment to improve glucose metabolism in people with prediabetes.
Categories
Diabetes and metabolic syndrome: The paper discusses a clinical trial that tests the use of morning light treatment to improve glucose metabolism in people with prediabetes.
Phototherapy: The paper discusses the use of a novel head worn light device (Re-Timer®) as an intervention to improve glucose metabolism in people with prediabetes.
Hormone regulation: The paper discusses how the central circadian clock, which regulates many circadian rhythms, can impact glucose regulation and how light treatment can alter circadian timing.
Author(s)
K Knutson
Related Publications
Diabetes and metabolic syndrome
- Endocrine regulation of circadian physiology
- Neurogenetic basis for circadian regulation of metabolism by the hypothalamus
- Spare the rods and spoil the retina: revisited
- Effect of experimental diabetic retinopathy on the non-image-forming visual system
- Cardio-ankle vascular index and indices of diabetic polyneuropathy in patients with type 2 diabetes
Phototherapy
- Phototransduction by retinal ganglion cells that set the circadian clock
- Strange vision: ganglion cells as circadian photoreceptors
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
- Short‐wavelength enrichment of polychromatic light enhances human melatonin suppression potency
Hormone regulation
- Phototransduction by retinal ganglion cells that set the circadian clock
- The impact of light from computer monitors on melatonin levels in college students
- Circadian rhythms–from genes to physiology and disease
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels
- Light pollution, circadian photoreception, and melatonin in vertebrates